HK Stock MarketDetailed Quotes

00570 TRAD CHI MED

Watchlist
  • 1.950
  • -0.060-2.99%
Noon Break Mar 31 11:59 CST
9.82BMarket Cap162.50P/E (TTM)

TRAD CHI MED Key Stats

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
(FY)Dec 31, 2020
(Q6)Jun 30, 2020
Turnover
-8.90%16.51B
-9.86%8.39B
26.69%18.12B
57.37%9.3B
-24.92%14.3B
-27.46%5.91B
28.68%19.05B
22.45%8.15B
3.39%14.81B
-4.06%6.66B
Operating income
-8.90%16.51B
-9.86%8.39B
26.69%18.12B
57.37%9.3B
-24.92%14.3B
-27.46%5.91B
28.68%19.05B
22.45%8.15B
3.39%14.81B
-4.06%6.66B
Cost of sales
2.19%-8.65B
4.86%-4.32B
-24.51%-8.85B
-53.56%-4.54B
1.63%-7.11B
5.94%-2.96B
-27.17%-7.22B
-19.26%-3.15B
1.13%-5.68B
4.05%-2.64B
Operating expenses
2.19%-8.65B
4.86%-4.32B
-24.51%-8.85B
-53.56%-4.54B
1.63%-7.11B
5.94%-2.96B
-27.17%-7.22B
-19.26%-3.15B
1.13%-5.68B
4.05%-2.64B
Gross profit
-15.29%7.86B
-14.64%4.06B
28.84%9.27B
61.19%4.76B
-39.15%7.2B
-41.00%2.95B
29.62%11.83B
24.54%5B
6.42%9.13B
-4.07%4.02B
Selling expenses
15.37%-5.42B
13.63%-2.75B
-39.08%-6.4B
-85.61%-3.19B
39.28%-4.6B
43.58%-1.72B
-35.71%-7.58B
-24.58%-3.04B
-9.35%-5.59B
0.43%-2.44B
Administrative expenses
-1.38%-1.06B
-10.20%-512.15M
-10.47%-1.04B
-15.72%-464.75M
3.08%-944.4M
-5.77%-401.61M
-37.77%-974.45M
-13.79%-379.7M
-3.07%-707.28M
-10.10%-333.68M
Research and development expenses
13.07%-596.01M
14.57%-267.93M
-12.06%-685.63M
1.23%-313.61M
11.90%-611.83M
-7.75%-317.53M
-26.15%-694.44M
-20.13%-294.7M
-18.64%-550.47M
-17.38%-245.32M
Impairment and provision
-1,037.67%-106.55M
-232.37%-158.77M
7.02%-9.37M
-29.33%-47.77M
27.42%-10.07M
20.19%-36.94M
74.17%-13.88M
-39.65%-46.28M
-198.32%-53.73M
36.19%-33.14M
-Other impairment is provision
-1,037.67%-106.55M
-232.37%-158.77M
7.02%-9.37M
-29.33%-47.77M
27.42%-10.07M
20.19%-36.94M
74.17%-13.88M
-39.65%-46.28M
-198.32%-53.73M
36.19%-33.14M
Special items of operating profit
-215.94%-341.22M
-78.55%14.83M
712.16%294.3M
-24.19%69.13M
-80.79%36.24M
18.56%91.19M
-28.22%188.63M
-47.42%76.91M
61.93%262.77M
74.22%146.27M
Operating profit
-76.49%335.59M
-52.76%384.58M
34.11%1.43B
42.82%814.05M
-61.34%1.06B
-56.68%569.97M
10.54%2.75B
18.73%1.32B
1.22%2.49B
-11.61%1.11B
Financing cost
13.82%-171.54M
20.07%-84.27M
9.81%-199.05M
-6.97%-105.44M
0.60%-220.7M
10.34%-98.57M
9.25%-222.03M
2.63%-109.93M
18.73%-244.67M
-1.25%-112.89M
Share of profits of associates
74.32%-950K
51.34%-874K
-6.32%-3.7M
-9.51%-1.8M
67.63%-3.48M
79.00%-1.64M
32.29%-10.75M
-60.66%-7.81M
-214.27%-15.87M
-194.01%-4.86M
Earning before tax
-86.68%163.11M
-57.64%299.43M
45.76%1.22B
50.46%706.81M
-66.67%840.11M
-60.78%469.77M
13.01%2.52B
20.96%1.2B
3.50%2.23B
-13.16%990.37M
Tax
-182.98%-142.34M
5.08%-85.29M
243.97%171.54M
-86.30%-89.85M
69.98%-119.14M
74.78%-48.23M
-7.42%-396.86M
-19.40%-191.24M
3.11%-369.45M
13.90%-160.17M
After-tax profit from continuing operations
-98.51%20.77M
-65.29%214.14M
93.64%1.4B
46.36%616.96M
-66.05%720.97M
-58.13%421.54M
14.12%2.12B
21.26%1.01B
4.93%1.86B
-13.02%830.2M
Earning after tax
-98.51%20.77M
-65.29%214.14M
93.64%1.4B
46.36%616.96M
-66.05%720.97M
-58.13%421.54M
14.12%2.12B
21.26%1.01B
4.93%1.86B
-13.02%830.2M
Minority profit
-130.03%-33.3M
-91.72%3.16M
354.75%110.87M
380.91%38.22M
-122.84%-43.52M
-89.66%7.95M
-3.46%190.57M
-21.72%76.85M
6.59%197.39M
3.00%98.18M
Profit attributable to shareholders
-95.79%54.07M
-63.55%210.98M
68.11%1.29B
39.93%578.74M
-60.45%764.49M
-55.52%413.59M
16.21%1.93B
27.02%929.83M
4.73%1.66B
-14.79%732.02M
Basic earnings per share
-95.81%0.0107
-63.53%0.0419
68.12%0.2552
39.95%0.1149
-60.45%0.1518
-55.53%0.0821
16.20%0.3838
26.96%0.1846
4.72%0.3303
-14.77%0.1454
Diluted earnings per share
-95.81%0.0107
-63.53%0.0419
68.12%0.2552
39.95%0.1149
-60.45%0.1518
-55.53%0.0821
16.20%0.3838
26.96%0.1846
0.3303
0.1454
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
Audit Opinions
--
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Auditor
--
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
--
Deloitte Guan Huang Chen Fang Certified Public Accountants
--
(FY)Dec 31, 2024(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021(FY)Dec 31, 2020(Q6)Jun 30, 2020
Turnover -8.90%16.51B-9.86%8.39B26.69%18.12B57.37%9.3B-24.92%14.3B-27.46%5.91B28.68%19.05B22.45%8.15B3.39%14.81B-4.06%6.66B
Operating income -8.90%16.51B-9.86%8.39B26.69%18.12B57.37%9.3B-24.92%14.3B-27.46%5.91B28.68%19.05B22.45%8.15B3.39%14.81B-4.06%6.66B
Cost of sales 2.19%-8.65B4.86%-4.32B-24.51%-8.85B-53.56%-4.54B1.63%-7.11B5.94%-2.96B-27.17%-7.22B-19.26%-3.15B1.13%-5.68B4.05%-2.64B
Operating expenses 2.19%-8.65B4.86%-4.32B-24.51%-8.85B-53.56%-4.54B1.63%-7.11B5.94%-2.96B-27.17%-7.22B-19.26%-3.15B1.13%-5.68B4.05%-2.64B
Gross profit -15.29%7.86B-14.64%4.06B28.84%9.27B61.19%4.76B-39.15%7.2B-41.00%2.95B29.62%11.83B24.54%5B6.42%9.13B-4.07%4.02B
Selling expenses 15.37%-5.42B13.63%-2.75B-39.08%-6.4B-85.61%-3.19B39.28%-4.6B43.58%-1.72B-35.71%-7.58B-24.58%-3.04B-9.35%-5.59B0.43%-2.44B
Administrative expenses -1.38%-1.06B-10.20%-512.15M-10.47%-1.04B-15.72%-464.75M3.08%-944.4M-5.77%-401.61M-37.77%-974.45M-13.79%-379.7M-3.07%-707.28M-10.10%-333.68M
Research and development expenses 13.07%-596.01M14.57%-267.93M-12.06%-685.63M1.23%-313.61M11.90%-611.83M-7.75%-317.53M-26.15%-694.44M-20.13%-294.7M-18.64%-550.47M-17.38%-245.32M
Impairment and provision -1,037.67%-106.55M-232.37%-158.77M7.02%-9.37M-29.33%-47.77M27.42%-10.07M20.19%-36.94M74.17%-13.88M-39.65%-46.28M-198.32%-53.73M36.19%-33.14M
-Other impairment is provision -1,037.67%-106.55M-232.37%-158.77M7.02%-9.37M-29.33%-47.77M27.42%-10.07M20.19%-36.94M74.17%-13.88M-39.65%-46.28M-198.32%-53.73M36.19%-33.14M
Special items of operating profit -215.94%-341.22M-78.55%14.83M712.16%294.3M-24.19%69.13M-80.79%36.24M18.56%91.19M-28.22%188.63M-47.42%76.91M61.93%262.77M74.22%146.27M
Operating profit -76.49%335.59M-52.76%384.58M34.11%1.43B42.82%814.05M-61.34%1.06B-56.68%569.97M10.54%2.75B18.73%1.32B1.22%2.49B-11.61%1.11B
Financing cost 13.82%-171.54M20.07%-84.27M9.81%-199.05M-6.97%-105.44M0.60%-220.7M10.34%-98.57M9.25%-222.03M2.63%-109.93M18.73%-244.67M-1.25%-112.89M
Share of profits of associates 74.32%-950K51.34%-874K-6.32%-3.7M-9.51%-1.8M67.63%-3.48M79.00%-1.64M32.29%-10.75M-60.66%-7.81M-214.27%-15.87M-194.01%-4.86M
Earning before tax -86.68%163.11M-57.64%299.43M45.76%1.22B50.46%706.81M-66.67%840.11M-60.78%469.77M13.01%2.52B20.96%1.2B3.50%2.23B-13.16%990.37M
Tax -182.98%-142.34M5.08%-85.29M243.97%171.54M-86.30%-89.85M69.98%-119.14M74.78%-48.23M-7.42%-396.86M-19.40%-191.24M3.11%-369.45M13.90%-160.17M
After-tax profit from continuing operations -98.51%20.77M-65.29%214.14M93.64%1.4B46.36%616.96M-66.05%720.97M-58.13%421.54M14.12%2.12B21.26%1.01B4.93%1.86B-13.02%830.2M
Earning after tax -98.51%20.77M-65.29%214.14M93.64%1.4B46.36%616.96M-66.05%720.97M-58.13%421.54M14.12%2.12B21.26%1.01B4.93%1.86B-13.02%830.2M
Minority profit -130.03%-33.3M-91.72%3.16M354.75%110.87M380.91%38.22M-122.84%-43.52M-89.66%7.95M-3.46%190.57M-21.72%76.85M6.59%197.39M3.00%98.18M
Profit attributable to shareholders -95.79%54.07M-63.55%210.98M68.11%1.29B39.93%578.74M-60.45%764.49M-55.52%413.59M16.21%1.93B27.02%929.83M4.73%1.66B-14.79%732.02M
Basic earnings per share -95.81%0.0107-63.53%0.041968.12%0.255239.95%0.1149-60.45%0.1518-55.53%0.082116.20%0.383826.96%0.18464.72%0.3303-14.77%0.1454
Diluted earnings per share -95.81%0.0107-63.53%0.041968.12%0.255239.95%0.1149-60.45%0.1518-55.53%0.082116.20%0.383826.96%0.18460.33030.1454
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards HKASHKASHKASHKASHKASHKASHKASHKASHKASHKAS
Audit Opinions ----Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--
Auditor ----Ernst & Young--Ernst & Young--Ernst & Young--Deloitte Guan Huang Chen Fang Certified Public Accountants--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
HK Dividend Stocks HK Dividend Stocks

Dividend stocks are stocks of companies in the HK stock market that regularly distribute dividends to shareholders, generally representing stable businesses. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in HK dividend stocks, ranked from highest to lowest based on real-time market data. Dividend stocks are stocks of companies in the HK stock market that regularly distribute dividends to shareholders, generally representing stable businesses. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in HK dividend stocks, ranked from highest to lowest based on real-time market data.